|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500100928 |
|
最近更新日期: Date of Last Refreshed on: |
2025-04-17 09:32:57 |
|
注册时间: Date of Registration: |
2025-04-17 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于生态系统理论模型中的中青年脑卒中家庭抗逆力变化轨迹的研究 |
|
Public title: |
Study on the trajectory of family resilience in middle-aged and young stroke patients based on ecosystem theory model |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于生态系统理论模型中的中青年脑卒中家庭抗逆力变化轨迹的研究 |
|
Scientific title: |
Study on the trajectory of family resilience in middle-aged and young stroke patients based on ecosystem theory model |
|
研究课题代号(代码): Study subject ID: |
2023QP02 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陆岳萍 |
研究负责人: |
陆岳萍 |
|
Applicant: |
Lu Yueping |
Study leader: |
Lu Yueping |
|
申请注册联系人电话: Applicant telephone: |
+86 138 5884 5365 |
研究负责人电话:
Study leader's |
+86 138 5884 5365 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
986040733@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
986040733@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
浙江省温州市鹿城区嘉福寺巷15号 |
研究负责人通讯地址: |
浙江省温州市鹿城区嘉福寺巷15号 |
|
Applicant address: |
15 Jiafusi Lane, Lucheng District, Wenzhou, Zhejiang |
Study leader's address: |
15 Jiafusi Lane, Lucheng District, Wenzhou, Zhejiang |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
325000 | |
|
申请人所在单位: |
中国人民解放军联勤保障部队第九〇六医院温州医疗区 |
||
|
Applicant's institution: |
People's Liberation Army 906 Hospital Wenzhou Medical District |
||
|
研究负责人所在单位: |
中国人民解放军联勤保障部队第九〇六医院温州医疗区 |
||
|
Affiliation of the Leader: |
People's Liberation Army 906 Hospital Wenzhou Medical District |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
第九〇六医院伦受2023研第007号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
第九〇六医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of 906th Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-12-28 00:00:00 | ||
|
伦理委员会联系人: |
贺新征 |
||
|
Contact Name of the ethic committee: |
He Xinzheng |
||
|
伦理委员会联系地址: |
浙江省宁波市鄞州区东胜街道中山东路377号 |
||
|
Contact Address of the ethic committee: |
377 Zhongshan East Road, Dongsheng Street, Yinzhou District, Ningbo, Zhejiang |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 132 8224 3433 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中国人民解放军联勤保障部队第九〇六医院温州医疗区 |
||||||||||||||||||||||
|
Primary sponsor: |
People's Liberation Army 906 Hospital Wenzhou Medical District |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省温州市鹿城区嘉福寺巷15号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
15 Jiafusi Lane, Lucheng District, Wenzhou, Zhejiang |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
院级课题经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Funding for research projects at the college level |
||||||||||||||||||||||
|
研究疾病: |
脑卒中 |
||||||||||||||||||||||
|
Target disease: |
stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
本研究旨在基于生态系统理论模型,探究中青年脑卒中患者家庭抗逆力变化轨迹及其影响因素,为提供更加科学的支持服务和干预措施提供理论依据。采用纵向研究设计,招募240名首次发生脑卒中的中青年患者及其240名家庭照顾成员,通过定期的问卷调查跟踪观察患者及其家庭的抗逆力变化情况。预期成果为描述中青年脑卒中患者家庭抗逆力的变化轨迹,确定主要影响因素。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on the ecosystem theory model, this study aims to explore the trajectory of family resilience and its influencing factors in young and middle-aged stroke patients, so as to provide a theoretical basis for more scientific support services and interventions. A longitudinal study design was used to recruit 240 young and middle-aged stroke patients and their 240 family members. The changes of resilience in patients and their families were followed up by regular questionnaires. The expected outcome was to describe the trajectory of changes in family resilience in young and middle-aged stroke patients and identify the main influencing factors. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①患者年龄范围:18-45岁。 ②符合脑卒中的临床标准,包括脑血管破裂或阻塞导致的急性脑组织缺血或出血,并经过相关的医学诊断和检查确认。 ③患者及其家庭成员愿意参与研究并提供相关数据。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Age range: 18-45 years. 2. meet the clinical criteria for stroke, including cerebral vascular rupture or occlusion caused by acute cerebral ischemia or hemorrhage, and confirmed by the relevant medical diagnosis and examination. 3. patients and their family members willing to participate in the study and provide relevant data. |
||||||||||||||||||||||
|
排除标准: |
①年龄不符合中青年范围。 ②其他神经系统疾病导致的认知和行为功能障碍。 ③存在严重的心理健康问题或无法配合研究要求的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. age does not meet the scope of young and middle-aged. 2.Cognitive and behavioral dysfunction due to other neurological disorder. 3.Patients with severe mental health problems or who were unable to comply with the study requirements. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-01-01 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-01-06 00:00:00 至 To 2024-09-24 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
NA |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2025-12,国家生物信息中心(https://ngdc.cncb.ac.cn/gsub/) |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2025-12,National Center for bioinformatics(https://ngdc.cncb.ac.cn/gsub/) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表及各类问卷调查表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case record form and all kinds of questionnaire |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |